https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1135007/full
Frontiers | Dose adjustment not required for contezolid in patients with moderate hepatic...
Objective: Contezolid is an oxazolidinone antimicrobial agent newly approved for treatment of Gram-positive bacterial infections. It is primarily metabolized...
not required